Soorya Ram Shimgekar

Soorya Ram Shimgekar, Abhay Goyal, Lam Yin Cheung et al.

Conspiratorial discourse is increasingly embedded within digital communication ecosystems, yet its structure and spread remain difficult to study. This work analyzes conspiratorial narratives in Singapore-based Telegram groups, showing that such content is woven into everyday discussions rather than confined to isolated echo chambers. We propose a two-stage computational framework. First, we fine-tune RoBERTa-large to classify messages as conspiratorial or not, achieving an F1-score of 0.866 on 2,000 expert-labeled messages. Second, we build a signed belief graph in which nodes represent messages and edge signs reflect alignment in belief labels, weighted by textual similarity. We introduce a Signed Belief Graph Neural Network (SiBeGNN) that uses a Sign Disentanglement Loss to learn embeddings that separate ideological alignment from stylistic features. Using hierarchical clustering on these embeddings, we identify seven narrative archetypes across 553,648 messages: legal topics, medical concerns, media discussions, finance, contradictions in authority, group moderation, and general chat. SiBeGNN yields stronger clustering quality (cDBI = 8.38) than baseline methods (13.60 to 67.27), supported by 88 percent inter-rater agreement in expert evaluations. Our analysis shows that conspiratorial messages appear not only in clusters focused on skepticism or distrust, but also within routine discussions of finance, law, and everyday matters. These findings challenge common assumptions about online radicalization by demonstrating that conspiratorial discourse operates within ordinary social interaction. The proposed framework advances computational methods for belief-driven discourse analysis and offers applications for stance detection, political communication studies, and content moderation policy.

Soorya Ram Shimgekar, Shayan Vassef, Abhay Goyal et al.

Building and deploying machine learning solutions in healthcare remains expensive and labor-intensive due to fragmented preprocessing workflows, model compatibility issues, and stringent data privacy constraints. In this work, we introduce an Agentic AI framework that automates the entire clinical data pipeline, from ingestion to inference, through a system of modular, task-specific agents. These agents handle both structured and unstructured data, enabling automatic feature selection, model selection, and preprocessing recommendation without manual intervention. We evaluate the system on publicly available datasets from geriatrics, palliative care, and colonoscopy imaging. For example, in the case of structured data (anxiety data) and unstructured data (colonoscopy polyps data), the pipeline begins with file-type detection by the Ingestion Identifier Agent, followed by the Data Anonymizer Agent ensuring privacy compliance, where we first identify the data type and then anonymize it. The Feature Extraction Agent identifies features using an embedding-based approach for tabular data, extracting all column names, and a multi-stage MedGemma-based approach for image data, which infers modality and disease name. These features guide the Model-Data Feature Matcher Agent in selecting the best-fit model from a curated repository. The Preprocessing Recommender Agent and Preprocessing Implementor Agent then apply tailored preprocessing based on data type and model requirements. Finally, the ``Model Inference Agent" runs the selected model on the uploaded data and generates interpretable outputs using tools like SHAP, LIME, and DETR attention maps. By automating these high-friction stages of the ML lifecycle, the proposed framework reduces the need for repeated expert intervention, offering a scalable, cost-efficient pathway for operationalizing AI in clinical environments.

Abhay Goyal, Navin Kumar, Kimberly DiMeola et al.

Chronic pain (CP) and opioid use disorder (OUD) are common and interrelated chronic medical conditions. Currently, there is a paucity of evidence-based integrated treatments for CP and OUD among individuals receiving medication for opioid use disorder (MOUD). Wearable devices have the potential to monitor complex patient information and inform treatment development for persons with OUD and CP, including pain variability (e.g., exacerbations of pain or pain spikes) and clinical correlates (e.g., perceived stress). However, the application of large language models (LLMs) with wearable data for understanding pain spikes, remains unexplored. Consequently, the aim of this pilot study was to examine the clinical correlates of pain spikes using a range of AI approaches. We found that machine learning models achieved relatively high accuracy (>0.7) in predicting pain spikes, while LLMs were limited in providing insights on pain spikes. Real-time monitoring through wearable devices, combined with advanced AI models, could facilitate early detection of pain spikes and support personalized interventions that may help mitigate the risk of opioid relapse, improve adherence to MOUD, and enhance the integration of CP and OUD care. Given overall limited LLM performance, these findings highlight the need to develop LLMs which can provide actionable insights in the OUD/CP context.